BCL2.

Christopher A G Booth1, Andrew A Lane1

  • 1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.

Trends in cancer
|October 2, 2023
PubMed
概括

抑制BCL2可以增强树突细胞功能,促进T细胞对抗瘤的激活. 这通过增强抗原呈现来提高免疫系统对抗癌症的能力.